|
GTF3C4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.62280000051796E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.07210000047198E-07 |
| Normal-vs-Stage2 |
3.819900E-03 |
| Normal-vs-Stage3 |
3.375900E-02 |
| Normal-vs-Stage4 |
9.728200E-02 |
| Stage1-vs-Stage2 |
7.257400E-01 |
| Stage1-vs-Stage3 |
3.414400E-01 |
| Stage1-vs-Stage4 |
8.334600E-01 |
| Stage2-vs-Stage3 |
6.556200E-01 |
| Stage2-vs-Stage4 |
9.649600E-01 |
| Stage3-vs-Stage4 |
7.186000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.09090000002909E-06 |
| Normal-vs-AfricanAmerican |
1.31119999968732E-07 |
| Normal-vs-Asian |
1.636910E-04 |
| Caucasian-vs-AfricanAmerican |
1.588360E-01 |
| Caucasian-vs-Asian |
3.690200E-01 |
| AfricanAmerican-vs-Asian |
5.098800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.15759995928033E-09 |
| Normal-vs-Female |
1.428180E-01 |
| Male-vs-Female |
5.740200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.6344000000026E-05 |
| Normal-vs-Extreme_Weight |
1.20019999494403E-08 |
| Normal-vs-Obese |
8.803000E-03 |
| Normal-vs-Extreme_Obese |
2.36529999999568E-05 |
| Normal_Weight-vs-Extreme_Weight |
6.374800E-01 |
| Normal_Weight-vs-Obese |
1.444370E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.236400E-01 |
| Extreme_Weight-vs-Obese |
2.110000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.923800E-01 |
| Obese-vs-Extreme_Obese |
1.750980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.950000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.259000E-03 |
| Normal-vs-Age(61-80Yrs) |
8.0484999775976E-09 |
| Normal-vs-Age(81-100Yrs) |
1.09000000025894E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.449800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.174600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.521420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.339900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.481000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.007370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.15469999953477E-07 |
| Normal-VS-Type2 PRCC |
7.55860000034581E-07 |
| Normal-VS-KIRP CIMP |
7.565200E-01 |
| Normal-VS-Unclassified PRCC |
1.151240E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.403400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.154500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.170230E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.064700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.864400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.637000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.5201999920863E-09 |
| Normal-vs-N1 |
4.481200E-01 |
| Normal-vs-N2 |
3.275600E-01 |
| N0-vs-N1 |
2.590100E-02 |
| N0-vs-N2 |
5.647800E-01 |
| N1-vs-N2 |
5.314200E-01 |
|
|
